Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.885 USD | -1.92% | -4.77% | +16.53% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
Evolution of the average Target Price on Wave Life Sciences Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Wave Life Sciences Ltd.
Wells Fargo Securities | |
Mizuho Securities | |
HC Wainwright | |
Leerink Partners | |
Raymond James | |
SVB Securities LLC | |
RBC Capital Markets | |
Stifel Nicolaus | |
SVB Leerink | |
Truist Securities |
EPS Revisions
- Stock Market
- Equities
- WVE Stock
- Consensus Wave Life Sciences Ltd.